Comparison of drug-coated balloon angioplasty versus common balloon angioplasty for arteriovenous fistula stenosis: A systematic review and meta-analysis.

Autor: Zhang Y; Department of Nephrology, Jianli People's Hospital, Jingzhou, China., Yuan FL; Department of Nephrology, The First Affiliated Hospital of Yangtze University, Jingzhou, China., Hu XY; Department of Emergency, The Central Hospital of Enshi Tujia and Miao Autonomous Prefecture, Enshi, China., Wang QB; Department of Emergency, The Central Hospital of Enshi Tujia and Miao Autonomous Prefecture, Enshi, China., Zou ZW; Department of General Practice, The Central Hospital of Enshi Tujia and Miao Autonomous Prefecture, Enshi, China., Li ZG; Department of Pediatrics, Jianli People's Hospital, Jingzhou, China.
Jazyk: angličtina
Zdroj: Clinical cardiology [Clin Cardiol] 2023 Aug; Vol. 46 (8), pp. 877-885. Date of Electronic Publication: 2023 Jul 07.
DOI: 10.1002/clc.24078
Abstrakt: Drug-coated balloons (DCBs) have been used in dialysis patients with arteriovenous fistula (AVF) stenosis, but whether DCBs have advantages over ordinary balloons is still controversial. A meta-analysis was designed to investigate the safety and efficacy of DCBs and common balloons (CBs) in the treatment of AVF stenosis. We searched the PubMed, EMBASE, and China National Knowledge Internet (CNKI) databases for randomized controlled trials that evaluated the comparison of DCB angioplasty versus CB angioplasty for AVF stenosis in dialysis patients and reported at least one outcome of interest. The results showed that the DCB group had a higher first-stage patency rate of the target lesion 6 months [odds ratio, OR = 2.31, 95% confidence interval, CI: (1.69, 3.15), p < .01] and 12 months [OR = 2.09, 95% CI: (1.50, 2.91), p < .01] after surgery. There was no statistically significant difference in all-cause mortality between the two groups at 6 months [OR = 0.85, 95% CI: (0.47, 1.52), p = .58] and 12 months [OR = 0.99, 95% CI: (0.60, 1.64), p = .97]. Compared with CB, DCBs as a new endovascular treatment for AVF stenosis have a higher primary patency rate of target lesions and can delay the occurrence of restenosis. There is no evidence that DCB can increase the mortality of patients.
(© 2023 The Authors. Clinical Cardiology published by Wiley Periodicals LLC.)
Databáze: MEDLINE
Externí odkaz: